Adam Laponis - 04 Nov 2024 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ Dennis Cho, as Attorney-in-Fact for Adam Laponis
Issuer symbol
TWST
Transactions as of
04 Nov 2024
Net transactions value
$0
Form type
4
Filing time
06 Nov 2024, 17:05:39 UTC
Previous filing
11 Oct 2024
Next filing
15 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +20,000 +27% $0.000000 93,397 04 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.